JP2774135B2 - 固体の急速に崩壊する剤形 - Google Patents

固体の急速に崩壊する剤形

Info

Publication number
JP2774135B2
JP2774135B2 JP1070719A JP7071989A JP2774135B2 JP 2774135 B2 JP2774135 B2 JP 2774135B2 JP 1070719 A JP1070719 A JP 1070719A JP 7071989 A JP7071989 A JP 7071989A JP 2774135 B2 JP2774135 B2 JP 2774135B2
Authority
JP
Japan
Prior art keywords
diclofenac
solid
effervescent
swellable
tablet according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP1070719A
Other languages
English (en)
Japanese (ja)
Other versions
JPH01283219A (ja
Inventor
ハーゲマン ルート
ビルト ダクマー
ブロネール アンリ―ジュリアン
Original Assignee
ノバルティス アクチェンゲゼルシャフト
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ノバルティス アクチェンゲゼルシャフト filed Critical ノバルティス アクチェンゲゼルシャフト
Publication of JPH01283219A publication Critical patent/JPH01283219A/ja
Application granted granted Critical
Publication of JP2774135B2 publication Critical patent/JP2774135B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP1070719A 1988-03-25 1989-03-24 固体の急速に崩壊する剤形 Expired - Lifetime JP2774135B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH01138/88-7 1988-03-25
CH1138/88A CH675537A5 (ko) 1988-03-25 1988-03-25

Publications (2)

Publication Number Publication Date
JPH01283219A JPH01283219A (ja) 1989-11-14
JP2774135B2 true JP2774135B2 (ja) 1998-07-09

Family

ID=4203378

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1070719A Expired - Lifetime JP2774135B2 (ja) 1988-03-25 1989-03-24 固体の急速に崩壊する剤形

Country Status (17)

Country Link
JP (1) JP2774135B2 (ko)
AT (1) AT400299B (ko)
AU (1) AU619261B2 (ko)
BE (1) BE1001706A3 (ko)
CA (1) CA1323837C (ko)
CH (1) CH675537A5 (ko)
DE (1) DE3909520C2 (ko)
DK (1) DK175517B1 (ko)
ES (1) ES2010466A6 (ko)
FR (1) FR2628971B1 (ko)
GB (1) GB2217598B (ko)
GR (1) GR890100182A (ko)
IE (1) IE61221B1 (ko)
IT (1) IT1232823B (ko)
NL (1) NL194999C (ko)
PT (1) PT90104B (ko)
SE (1) SE8901003L (ko)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE509029C2 (sv) * 1988-08-16 1998-11-30 Ss Pharmaceutical Co Långtidsverkande diklofenak-natriumpreparat
GB8824392D0 (en) * 1988-10-18 1988-11-23 Ciba Geigy Ag Dispersible formulation
DE4403943A1 (de) * 1994-02-08 1995-08-10 Hexal Pharma Gmbh Orale Azrneimittelzubereitung mit Diclofenac-Natrium
DE19530575A1 (de) * 1995-08-19 1997-02-20 Gruenenthal Gmbh Schnell zerfallende Arzneiform von Tramadol oder einem Tramadolsalz
JP3950175B2 (ja) * 1997-05-30 2007-07-25 オスモティカ・コーポレイション 多層浸透デバイス
IT1293764B1 (it) * 1997-07-23 1999-03-10 Chiesi Farma Spa Composizioni farmaceutiche sotto forma di compresse effervescenti contenenti un principio attivo instabile in presenza di acqua
WO2001010405A1 (en) * 1999-08-04 2001-02-15 Ranbaxy Laboratories Limited Hydrodynamically balanced oral drug delivery system
WO2004089343A1 (en) * 2003-04-09 2004-10-21 Ranbaxy Laboratories Limited Water soluble tablets
JP4575654B2 (ja) * 2003-09-05 2010-11-04 エスエス製薬株式会社 溶解性と流動性を改善した医薬組成物
FR2902657B1 (fr) * 2006-06-21 2009-01-16 Virbac Sa Sa Granules ou granules effervescents
WO2009106824A2 (en) * 2008-02-25 2009-09-03 Cipla Limited Pharmaceutical formulations
EP2773204A4 (en) 2011-10-31 2015-05-27 Glaxosmithkline Intellectual Property Ltd Pazopanib FORMULATION
WO2013109224A1 (en) * 2012-01-18 2013-07-25 Mahmut Bilgic Pharmaceutical compositions comprising diclofenac
US11957792B2 (en) * 2012-04-19 2024-04-16 Glatt Ag Taste-masked pharmaceutical compositions containing diclofenac
DE202022100544U1 (de) 2022-01-31 2022-02-16 Ranjitsing Babasing Bayas Neue orale Streifen- oder Dünnfilmform von Diclofenac-Natrium

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4826204A (ko) * 1971-08-11 1973-04-06
GB1371035A (en) * 1971-09-21 1974-10-23 Rolls Royce Method of etching aluminium alloys
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
EP0052075A1 (de) * 1980-11-12 1982-05-19 Ciba-Geigy Ag Körnige Arzneimittel-Retardform
EP0052076B1 (de) * 1980-11-12 1985-05-29 Ciba-Geigy Ag Schnellzerfallende Arzneimittel-Presslinge
CH655507B (ko) * 1983-01-12 1986-04-30
DE3446873A1 (de) * 1984-12-21 1986-07-10 Merckle Gmbh Fluessige diclofenac-zubereitungen
CH664085A5 (de) * 1985-02-08 1988-02-15 Ciba Geigy Ag Pharmazeutische praeparate mit analgetischer wirksamkeit, sowie deren herstellung.
IE59106B1 (en) * 1985-05-31 1994-01-12 Warner Lambert Co A therapeutic effervescent composition and a method of preparing the same
LU85943A1 (fr) * 1985-06-12 1987-01-13 Galephar Comprimes pharmaceutiques permettant l'administration aisee de pellets, leur preparation et leur utilisation
DE3607339A1 (de) * 1986-03-06 1987-09-10 Merck Patent Gmbh Pharmazeutische zubereitung
DE3612537C1 (de) * 1986-04-14 1987-07-16 Dispersa Ag Arzneimittel zur Behandlung von Entzuendungen im Auge
EP0243521A1 (de) * 1986-04-30 1987-11-04 Werner Prof. Dr. Thorn Oral verabreichbares Präparat
IT1200178B (it) * 1986-07-23 1989-01-05 Alfa Farmaceutici Spa Formulazioni galeniche a cessione programmata contenenti farmaci ad attivita' antiflogistica
US4710384A (en) * 1986-07-28 1987-12-01 Avner Rotman Sustained release tablets made from microcapsules
CH673395A5 (ko) * 1987-01-30 1990-03-15 Ciba Geigy Ag

Also Published As

Publication number Publication date
DE3909520C2 (de) 1998-12-10
SE8901003D0 (sv) 1989-03-21
ES2010466A6 (es) 1989-11-01
DK147189A (da) 1989-09-26
GB2217598A (en) 1989-11-01
IT1232823B (it) 1992-03-05
IE890934L (en) 1989-09-25
IT8947756A0 (it) 1989-03-20
GR890100182A (el) 1990-01-19
CH675537A5 (ko) 1990-10-15
FR2628971B1 (fr) 1994-02-18
FR2628971A1 (fr) 1989-09-29
JPH01283219A (ja) 1989-11-14
SE8901003L (sv) 1989-09-26
AT400299B (de) 1995-11-27
PT90104A (pt) 1989-11-10
AU3163489A (en) 1989-09-28
AU619261B2 (en) 1992-01-23
CA1323837C (en) 1993-11-02
IE61221B1 (en) 1994-10-19
ATA69089A (de) 1995-04-15
PT90104B (pt) 1994-06-30
GB8906414D0 (en) 1989-05-04
NL194999C (nl) 2003-05-08
BE1001706A3 (fr) 1990-02-13
GB2217598B (en) 1992-01-08
DK175517B1 (da) 2004-11-15
NL8900734A (nl) 1989-10-16
DK147189D0 (da) 1989-03-22
DE3909520A1 (de) 1989-10-05

Similar Documents

Publication Publication Date Title
US5211957A (en) Solid rapidly disintegrating dosage form
KR880001753B1 (ko) 브롬헥신 서방출성 제형의 제조방법
JP5132721B2 (ja) ＨＭＧ−ＣｏＡ還元酵素阻害剤の徐放性改良製剤
JP5783489B2 (ja) トロスピウムの１日１回剤形
JP3148256B2 (ja) 高用量難溶性薬物用持続放出マトリックス
JP2774135B2 (ja) 固体の急速に崩壊する剤形
JP2753297B2 (ja) 薬学的製剤
JP4749639B2 (ja) 味がマスクされ、活性成分を即時放出する、被覆された顆粒の製造方法
ES2606463T3 (es) Combinación de formas de dosificación de levodopa/carbidopa de liberación inmediata y liberación controlada
ES2337547T3 (es) Composiciones de liberacion controlada que contienen nimesulida.
CA2268868C (en) Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
JPH0251402B2 (ko)
JPH0710773B2 (ja) 一定の放出性及び即時放出性を有する薬物粒子
JPH0733330B2 (ja) 弾性被膜を有する安定な固形調剤及びその製造方法
JPH07558B2 (ja) モピダモール製剤
WO2002017885A2 (en) Controlled release formulation of erythromycin or a derivative thereof
JP2665858B2 (ja) 持効性塩酸オキシブチニン製剤
JPH09508381A (ja) 放出調節型メトロニダゾール組成物およびその製造方法と使用方法
US20020132002A1 (en) Sustained release pharmaceutical formulation
JP2012140335A (ja) 不快味マスキング粒子及びこれを含有する経口製剤
ES2317450T3 (es) Formulacion de liberacion controlada de acido valproico y sus derivados.
EP0121901A1 (en) pH independent controlled releasable tablets
US20100034887A1 (en) Bursting Pellets
JPH057365B2 (ko)
WO2009047800A2 (en) Oral controlled release composition of carvedilol

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090424

Year of fee payment: 11

EXPY Cancellation because of completion of term